Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

ACRX

AcelRX Pharmaceuticals (ACRX)

AcelRX Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ACRX
DateTimeSourceHeadlineSymbolCompany
03/31/20224:10PMPR Newswire (US)AcelRx Pharmaceuticals Announces Publication of Results from a Clinical Study Assessing Use of Sufentanil Sublingual Tablet for Painful Radiofrequency Microneedling ProceduresNASDAQ:ACRXAcelRX Pharmaceuticals Inc
03/29/20221:08PMPR Newswire (US)AcelRx Pharmaceuticals Announces Publication of Clinical Data Finding Potential Benefits of Nafamostat Compared to Regional Citrate for Anticoagulation of the Dialysis CircuitNASDAQ:ACRXAcelRX Pharmaceuticals Inc
03/10/20225:29PMEdgar (US Regulatory)Annual Report (10-k)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
03/10/20224:07PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
03/10/20224:01PMPR Newswire (US)AcelRx Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial ResultsNASDAQ:ACRXAcelRX Pharmaceuticals Inc
03/04/20224:29PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
03/04/20224:28PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
03/03/20224:05PMPR Newswire (US)AcelRx to Host Fourth Quarter and Full Year 2021 Financial Results Call and Webcast on March 10, 2022NASDAQ:ACRXAcelRX Pharmaceuticals Inc
02/15/20226:31AMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
02/14/20226:24PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
02/14/20225:35PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
02/14/20224:46PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
02/01/20228:30AMPR Newswire (US)AcelRx Pharmaceuticals Announces Publication of Clinical Data on the Use of Sufentanil Sublingual Tablet during Awake Plastic Surgery ProceduresNASDAQ:ACRXAcelRX Pharmaceuticals Inc
01/30/202212:45AMTipRanksH.C. Wainwright Thinks Acelrx’s Stock is Going to RecoverNASDAQ:ACRXAcelRX Pharmaceuticals Inc
01/27/20222:52PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
01/27/20228:30AMPR Newswire (US)AcelRx Pharmaceuticals Announces Publication of an Article Highlighting the Utility of the Sufentanil Sublingual Tablet in Pain Medicine ProceduresNASDAQ:ACRXAcelRX Pharmaceuticals Inc
01/24/20224:21PMEdgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
01/12/20224:02PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
01/12/20228:30AMPR Newswire (US)AcelRx Pharmaceuticals Announces Publication of an Editorial by an Internationally Recognized Leader in Opioid-Sparing Surgery Highlighting the Potential Advantages of the Sufentanil Sublingual Tablet in Joint Replacement SurgeryNASDAQ:ACRXAcelRX Pharmaceuticals Inc
01/10/20228:30AMPR Newswire (US)AcelRx Pharmaceuticals Announces the Closing of its Acquisition of Lowell TherapeuticsNASDAQ:ACRXAcelRX Pharmaceuticals Inc
12/15/20218:30AMPR Newswire (US)AcelRx Pharmaceuticals Announces Publication of Clinical Data Showing Reduced Hospital Length of Stay and Reduced Opioid Utilization with Use of Sublingual Sufentanil in Total Joint Replacement SurgeryNASDAQ:ACRXAcelRX Pharmaceuticals Inc
12/03/20214:49PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
11/23/20215:43PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
11/23/20215:39PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
11/23/20215:32PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
11/23/20215:09PMPR Newswire (US)AcelRx Pharmaceuticals Announces the Appointment of Jill Broadfoot to its Board of DirectorsNASDAQ:ACRXAcelRX Pharmaceuticals Inc
11/15/20217:34AMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
11/15/20216:56AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
11/15/20216:45AMPR Newswire (US)AcelRx Announces $14 Million Registered Direct Common Stock and Warrant OfferingNASDAQ:ACRXAcelRX Pharmaceuticals Inc
11/15/20216:39AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:ACRX